Application 091045
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | METOPROLOL TARTRATE | METOPROLOL TARTRATE | INJECTABLE;INJECTION | 1MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51662-1365 | METOPROLOL TARTRATE | METOPROLOL TARTRATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1365 | METOPROLOL TARTRATE | METOPROLOL TARTRATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1365 | METOPROLOL TARTRATE | METOPROLOL TARTRATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 63323-660 | Metoprolol | METOPROLOL TARTRATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-660 | Metoprolol | METOPROLOL TARTRATE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-660 | Metoprolol | METOPROLOL TARTRATE | Fresenius Kabi USA, LLC | ANDA | Current |